743 related articles for article (PubMed ID: 12016314)
1. Vitamin D receptor as an intestinal bile acid sensor.
Makishima M; Lu TT; Xie W; Whitfield GK; Domoto H; Evans RM; Haussler MR; Mangelsdorf DJ
Science; 2002 May; 296(5571):1313-6. PubMed ID: 12016314
[TBL] [Abstract][Full Text] [Related]
2. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.
Staudinger JL; Goodwin B; Jones SA; Hawkins-Brown D; MacKenzie KI; LaTour A; Liu Y; Klaassen CD; Brown KK; Reinhard J; Willson TM; Koller BH; Kliewer SA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3369-74. PubMed ID: 11248085
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
6. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
[TBL] [Abstract][Full Text] [Related]
7. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.
Pascussi JM; Gerbal-Chaloin S; Drocourt L; Maurel P; Vilarem MJ
Biochim Biophys Acta; 2003 Feb; 1619(3):243-53. PubMed ID: 12573484
[TBL] [Abstract][Full Text] [Related]
8. Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.
Ishizawa M; Akagi D; Makishima M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986424
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.
Masuno H; Ikura T; Morizono D; Orita I; Yamada S; Shimizu M; Ito N
J Lipid Res; 2013 Aug; 54(8):2206-2213. PubMed ID: 23723390
[TBL] [Abstract][Full Text] [Related]
10. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
[TBL] [Abstract][Full Text] [Related]
11. 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro.
Zierold C; Mings JA; Deluca HF
Mol Pharmacol; 2006 May; 69(5):1740-7. PubMed ID: 16484501
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
[TBL] [Abstract][Full Text] [Related]
14. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
Ikura T; Ito N
Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
17. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
18. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
Herdick M; Carlberg C
J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid can carry out in vivo functions of vitamin D.
Nehring JA; Zierold C; DeLuca HF
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10006-9. PubMed ID: 17535892
[TBL] [Abstract][Full Text] [Related]
20. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
Matsubara T; Yoshinari K; Aoyama K; Sugawara M; Sekiya Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2008 Oct; 36(10):2058-63. PubMed ID: 18645036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]